This report explores model changes that allowed for clinical trial efficiencies from the perspective of the CRO and is based on a set of workshops with COVID-19 vaccine clinical delivery teams.

データと分析による次世代型の臨床開発アプローチで、より早い治療アウトカムの実現を支援 “IQVIA CORE” 駆動型の革新的パフォーマンス より精密に、よりスピーディーに 従来の課題を新たな機会と捉え、実効性をもつ一連のソリューションで臨床試験を ...

4 天之前 · IQVIA’s research and development solutions enables you to reimagine clinical development by leveraging advances in technology, analytics and human ingenuity.

RESEARCH TRIANGLE PARK, N.C.-- (BUSINESS WIRE)-- IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry was named the top CRO in Overall Reputation by clinical trial sites around the world in the 2021 WCG CenterWatch Global Site Relationship ...

IQVIA is named a top CRO in Overall Reputation in the 2021 WCG CenterWatch Global Site Relationship Benchmark Survey Report. A win for the organization, and our employees.

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more …

＜IQVIAジャパン 企業概要＞ IQVIAジャパン グループ 会長 湊 方彦 IQVIAサービシーズ ジャパン合同会社 （旧社名：クインタイルズ・トランスナショナル・ジャパン株式会社） ＜CRO・CSO事業＞ 社長 宇賀神 史彦

IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical …

IQVIA Laboratories will enhance your full service offering to the market and ultimately your clinical delivery by partnering with you in an operating model designed specifically for CROs.

A IQVIA é líder global no uso de informação, tecnologia, análises avançadas e expertise humana para ajudar seus clientes a impulsionar a área da saúde.